Navigation Links
ShangPharma Announces Second Quarter 2011 Results
Date:8/22/2011

ures also facilitate management's internal comparisons to the Company's historical performance. The Company computes its non-GAAP financial measures using the same consistent method from quarter to quarter. The Company believes these non-GAAP financial measures are useful to investors in allowing for greater transparency with respect to supplemental information used by management in its financial and operational decision making. A limitation of using non-GAAP financial measures excluding expenses relating to or the effect of share-based compensation is that these expenses and effects have been and will continue to be significant recurring expenses in the Company's business for the foreseeable future. Management compensates for these limitations by providing specific information regarding the GAAP amount excluded from each non-GAAP measure. The accompanying tables have more details on the reconciliation between non-GAAP financial measures and their most comparable GAAP financial measures.

For further information, please contact:ShangPharma CorporationIn Shanghai, China
Lan Xie
VP of Finance and Operations
E-mail: IR@shangpharma.comChristensen

In New York, US
Kimberly Minarovich, +1 917-533-3268
kminarovich@christensenir.comIn Hong Kong
Tip Fleming, +852-9212-0684
tfleming@christensenir.comSHANGPHARMA CORPORATIONUNAUDITED CONSOLIDATED BALANCE SHEET(in thousands of U.S. dollars, except for ordinary share data) 

 

December 31,

June 30,  

 

2010

2011 ASSETSCurrent assets: 

 Cash and cash equivalents

49,160

41,550 

 Restricted cash

688

840 

 Accounts receivable, net

16,908

20,261 

 A
'/>"/>

SOURCE ShangPharma Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. ShangPharma Corporation Named a Top Ten Chinese Outsourcing Enterprise
2. ShangPharma Announces First Quarter 2011 Results
3. ShangPharma Corp. to Announce Fourth Quarter and Full Year 2010 Financial Results on March 15, 2011
4. Stem Cell Assurance, Inc. Announces Change of Name to BioRestorative Therapies, Inc.
5. Syndax Pharmaceuticals Announces Issuance of EU Patent for Entinostat
6. Regeneron Announces Review of Biologics License Application for EYLEA™ (aflibercept injection) Extended by Three Months by FDA
7. ACMG Announces New Online Live Learning Center: Will Bring Genetics and Genomics Education to Varied Health Professionals
8. Neurologix Announces Second Quarter 2011 Financial Results
9. Bion Announces New U.S. Patent for Phosphorus Removal
10. ViaCyte Announces Executive Management Changes
11. NeoStem Announces the Receipt of Over $1,700,000 in DOD Funding for its VSEL™ Technology Being Developed to Treat Osteoporosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... , Nov. 18, 2014  Novira Therapeutics, Inc., ... curative treatment of chronic hepatitis B virus (HBV) infection, ... was appointed to its Scientific Advisory Board (SAB).  ... our SAB," said Christian S. Schade , Chief ... clinical development experience which will be invaluable to Novira ...
(Date:11/15/2014)... November 13, 2014 Collaborative Consulting, a ... were named one of the Boston Globe’s “Top Places ... Sized Businesses in Massachusetts to receive the honor. , ... who take care of their most valuable resource: the ... presented annually, and are based on an array of ...
(Date:11/15/2014)... Phoenix, AZ (PRWEB) November 14, 2014 ... the DNA analysis market has already proven itself as ... consumer usage. DNA Spectrum recognizes this opportunity with its ... provides customers with a comprehensive genealogical history for a ... myDNA Safe storage service and forthcoming ...
(Date:11/15/2014)... LONDON , Nov. 14, 2014 Algenol Biofuels ... 6th at the Oceanographic Museum of Monaco ... CleanEquity Monaco is an annual invitation-only event hosted by ... investment bank. Other partners and sponsors include ... Foundation, Covington & Burling, Cranfield University, PR Newswire, the Monte-Carlo ...
Breaking Biology Technology:Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 2Novira Therapeutics Announces Appointment of Brian F. Daniels, M.D., to its Scientific Advisory Board 3Collaborative Consulting Honored with Boston Globe Top Places to Work 2014 2DNA Spectrum Begins the Search For a New Chief Executive Officer 2DNA Spectrum Begins the Search For a New Chief Executive Officer 3Algenol Biofuels Selected to Present at CleanEquity Monaco 2015 2
... HGS reacquires GSK rights to TRAIL receptor antibodies in return for ... reduction in Syncria(R) royalties - ... development program expands -, ROCKVILLE, Md., April 16 Human Genome,Sciences, ... the TRAIL receptor antibodies HGS-ETR1 (mapatumumab) and HGS-ETR2,(lexatumumab) from GlaxoSmithKline (GSK), in ...
... April 16 Masimo (Nasdaq:,MASI), the inventor ... announced an,agreement with Atom Medical Corporation, a ... to integrate Masimo Rainbow SET Pulse,CO-Oximetry into ... "Since standardizing on Masimo technology more than ...
... On Wednesday, April,23, 2008, GlaxoSmithKline plc will announce ... ended March 31, 2008. The announcement is,scheduled to ... approximately 7:00,am (ET) US and will be available ... Following the announcement, JP Garnier, Chief Executive Officer ...
Cached Biology Technology:Human Genome Sciences Advances Oncology Portfolio 2Human Genome Sciences Advances Oncology Portfolio 3Human Genome Sciences Advances Oncology Portfolio 4Human Genome Sciences Advances Oncology Portfolio 5Human Genome Sciences Advances Oncology Portfolio 6Atom Medical Adopts Masimo Rainbow SET Technology 2Atom Medical Adopts Masimo Rainbow SET Technology 3Atom Medical Adopts Masimo Rainbow SET Technology 4
(Date:11/4/2014)... research study examining only marketing directed at children ... restaurants has found that the majority of black, ... such marketing tactics. , Authored by Arizona State ... study is the first to examine the use ... of fast food restaurants and its relationship to ...
(Date:11/4/2014)... A majority of Madagascar,s 101 species of lemurs are ... for the rainforests they call home. A new study ... can have on rainforest tree populations, which raises concerns ... the region,s rich biodiversity. , A large proportion of ... Lemurs in turn disperse the seeds of their ...
(Date:11/3/2014)... , Nov. 3, 2014 Research and ... "Cell Therapy - Technologies, Markets and Companies" to ... cell therapy technologies and methods, which have already started to ... stem cell transplantation is replacing the old fashioned bone marrow ... Cell therapy is bound to become a part of medical ...
Breaking Biology News(10 mins):Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3Gardeners of Madagascar rainforest at risk 2Gardeners of Madagascar rainforest at risk 3Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 3
... and breadth of coverage, applicability and usefulness of the ... (GBIF) has set a goal of making one billion ... portal by December 2008., GBIF calls on holders of ... sharing their data to deepen and broaden biodiversity data ...
... another layer of competition to the mating game, scientists ... of female mammals can sense the presence of sperm ... This may be the molecular mechanism behind post-copulatory sexual ... partners play a role in determining which sperm fertilizes ...
... conservationists in Manchester are turning to physics to investigate ... American tree frogs. In a unique collaborative project, ... University of Manchester have joined forces with The Manchester ... frogs. Physicist Dr Mark Dickinson, working with Andrew ...
Cached Biology News:GBIF sets goal of mobilizing 1 billion records by end of 2008 2New evidence for female control in reproduction 2New evidence for female control in reproduction 3Sunbathing tree frogs' future under a cloud 2
Human Cystatin A MAb (Clone 224705)...
...
Microlite 2+ Plate, round bottom; an irradiated, high binding surface with enhanced dynamic range, extra high reflectivity and minimal cross talk for low signal luminescent reactions....
... temperature freezers offer a superior sample ... biological samples with high capacities. Innovative ... doors ensure excellent warming protection and ... oriented accessories simplify tracking of sample ...
Biology Products: